2026 - Director Statement PT MPI Maret 2026.pdf

ana

PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

SURAT PERNYATAAN DIREKSI
TENTANG TANGGUNG JAWAB ATAS
LAPORAN KEUANGAN KONSOLIDASIAN INTERIM
31 MARET 2026 DAN 31 DESEMBER 2025
SERTA UNTUK PERIODE TIGA BULAN YANG

DIRECTORS? STATEMENT
REGARDING THE RESPONSIBILITY FOR

THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS

31 MARCH 2026 AND 31 DECEMBER 2025
AND FOR THE THREE MONTHS PERIOD ENDED

BERAKHIR PADA 31 MARET 2026 DAN 2025 31 MARCH 2026 AND 2025
PT MILLENNIUM PHARMACON INTERNATIONAL Tbk PT MILLENNIUM PHARMACON INTERNATIONAL Tbk
DAN ENTITAS ANAK AND ITS SUBSIDIARY
Nama Dr.Imam Fathorrahman MM. Name
Alamat kantor Crown Bungur Arteri Lt, 2-4 Office address

JL Sultan Iskandar Muda No. 18
Kel. Kebayoran Lama Selatan,
Kec. Kebayoran Lama - Jakarta Selatan
JL Tebet Utara IV B No.3 RT 003/002
Kel. Tebet Timur, Kec. Tebet -
Jakarta Selatan
(62-21) 27085961

Alamat domisili Residential Address

Nomor telepon Phone Number

Jabatan Direktur Utama/ President Director Position
Nama Mohamad Fazly bin Hassan Name
Alamat kantor Crown Bungur Arteri Lt, 2-4 Office address
JL Sultan Iskandar Muda No. 18
Kel. Kebayoran Lama Selatan,
Kec. Kebayoran Lama - Jakarta Selatan
Alamat domisili JL. Apartement Hamptons Park Residential Address

Tower A Unit 8 F,

Jl Terogong Raya No. 18 Cilandak Barat
(62-21) 27085961
Direktur/ Director

Nomor telepon
Jabatan

Phone Number
Position
menyatakan bahwa: declare that:

1. Kami bertanggung jawab atas penyusunan dan 1. We are responsible for the preparation and

penyajian laporan — keuangan

konsolidasian

interim PT Millennium Pharmacon International Tbk

dan entitas anak,

2. Laporan keuangan

konsolidasian

PT Millennium Pharmacon International Tbk dan
entitas anak telah disusun dan disajikan sesuai
dengan Standar Akuntansi Keuangan di Indonesia,

interim 2

presentation of the interim consolidated financial
statements of PT Millennium Pharmacon International
Tbk and its subsidiary,

The interim consolidated financial statements of
PT Millennium Pharmacon International Tbk and its
subsidiary have been prepared and presented in
accordance with the Financial Accounting Standards
in Indonesia,

3... Semua informasi dalam laporan keuangan 3. a. All information in the interim consolidated
konsotidasian interim PT Millennium Pharmacon financial statements of PT Millennium
International Tbk dan entitas anak telah dimuat Pharmacon International Tbk and its subsidiary
secara lengkap dan benar, have been disclosed in a complete and truthful

manner,

b. Laporan keuangan konsolidasian interim b. The interim consolidated financial statements
PT Millennium Pharmacon International Tbk dan of PT Millennium Pharmacon International Tbk
entitas anak tidak mengandung informasi atau and its subsidiary do not contain misleading
fakta material yang tidak benar, dan tidak material information or facts, and do not
menghilangkan informasi atau fakta material, conceal any material information or facts:

4. Bertanggung jawab atas sistem pengendalian intern 4. We are responsible for PT Millennium 'Pharmacon

dalam PT Millennium Pharmacon International Tbk

dan entitas anak.

Demikian pernyataan ini dibuat dengan sebenarnya.

Dr.Imam Fathorrahman MM.
Direktur Utama/ President Director

International Tbk and its subsidiary's internal control
system.

This statement letter is made truthfully.

Jakarta, 29 April/April 2026

Mohamad Fazly bin Hassan
Direktur/Director

Crown Bungur Arteri 2-4th Floors

Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia

Phone : #6221 27085961